Inactive Instrument

Press Releases GlaxoSmithKline plc London S.E.

Equities

End-of-day quote London S.E. Other stock markets
- ^GBX	-

Jul. 11	European Equities Close Higher Thursday; UK GDP Grows More Than Expected	MT
Jul. 11	GSK: first shipments of flu vaccines to the USA	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK : Q2 2024 pre announcement aide memoire	Jul. 12	PU
Severe Asthma Pipeline 2024 \| Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera	Jul. 12	AQ
Neuroendocrine Tumors Pipeline 2024 \| Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene	Jul. 12	AQ
GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season	Jul. 11	BU
Liver Cancer Pipeline 2024 \| Arcus Biosciences, Yiviva, Virogin Biotech, Tvardi Therapeutics, GlaxoSmithKline, TORL Biotherapeutics, AVEO Pharmaceuticals, Teclison, Epizyme, Sirnaomics	Jul. 10	AQ
Brazil and Thailand become first malaria-endemic countries to launch new single-dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria \| GSK	Jul. 08	AQ
GSK : Brazil and Thailand become first malaria endemic countries to launch new single dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria	Jul. 05	PU
GSK and CureVac to restructure collaboration into new licensing agreement \| GSK	Jul. 04	AQ
GSK : and CureVac to restructure collaboration into new licensing agreement Form 6 K	Jul. 03	PU
GSK plc - Statement, Zantac litigation, Gross case	Jul. 01	AQ
Statement: Zantac (ranitidine) litigation - Gross case \| GSK	Jul. 01	AQ
Statement: Zantac (ranitidine) litigation Gross case Form 6 K	Jun. 28	PU
GSK plc - Statement, US Centers for Disease Control and Prevention's Advisory Committee on Immunisation Practices updates recommendations on adult RSV vaccines ahead of the next season	Jun. 27	AQ
Statement: US Centers for Disease Control and Prevention’s Advisory Committee on Immunisation Practices updates recommendations on adult RSV vaccines ahead of the next season	Jun. 26	PU
GSK's Omjjara (momelotinib) approved in Japan for treatment of myelofibrosis \| GSK	Jun. 25	AQ
Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients with primary advanced or recurrent endometrial cancer \| GSK	Jun. 25	AQ
GSK : Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients with primary advanced or recurrent endometrial cancer Form 6 K	Jun. 24	PU
GSK : Omjjara (momelotinib) approved in Japan for treatment of myelofibrosis Form 6 K	Jun. 24	PU
GSK : Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients with primary advanced or recurrent endometrial cancer	Jun. 24	PU
GSK : Director/Pdmr Shareholding Form 6 K	Jun. 21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK PLC : Frightened markets create an entry opportunity in GSK

June 04, 2024 at 08:38 am EDT

GSK plc : Back on track

May 03, 2024 at 05:17 am EDT